Chief Executive Officer
Sanjay Gupta is an investor and serial entrepreneur with specific interests in disruptive innovation, healthcare and sustainability. Currently, he serves as the Managing Partner of Tau Investment Management. Prior, he served as Senior Vice-President and Adviser to the Executive Chairman of Abraxis BioScience. In 2010, Gupta participated in the sale of Abraxis BioScience in a public transaction valued at US$ 2.9 billion. He was also Director of Social Enterprise at Intel Corporation, and Chief Financial Officer and Director of Strategy for Dossia. Gupta was previously Managing Director and Founder of REALSTRATEGY, a consulting firm based in the US, and was also a Partner at Geo Health Partners, an investment partnership which focused on healthcare investments domestically and internationally. Gupta was educated at the University of Oxford, where he earned an MBA and was a Member of Merton College. He studied philosophy at Georgetown University and Bioethics at the Kennedy Institute of Ethics.